Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 20, 2006

OGT Grants DNA Sequence Variation Rights to Illumina

  • Illumina obtained permission to Oxford Gene Technology’s (OGT) patents for the detection of DNA sequence variations. The granted license will remain valid for the lifetime of the patents.

    Under the license agreement, Illumina gained certain rights with respect to SNP genotyping. “OGT’s technology combined with Illumina’s BeadArray™ technology gives customers access to an extremely powerful SNP detection platform,” says Sue Sutton, vp, Licensing North America at OGT.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »